ARMISTICE CAPITAL, LLC - 30 Jun 2025 SCHEDULE 13G/A Report for SUPERNUS PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share (PMN)

Filing Manager: ARMISTICE CAPITAL, LLC
Reporting Manager: Armistice Capital, LLC
Security: SUPERNUS PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share
Symbol: PMN
Shares outstanding: 56,083,916 shares
Disclosed Ownership: 4,812,000 shares
Ownership: 8.6%
Form type: SCHEDULE 13G/A
Filing time: 15 Aug 2025, 12:28:45 UTC
Date of event: 30 Jun 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Armistice Capital, LLC	8.6%	4,812,000	0	4,812,000	/s/ Steven Boyd	Steven Boyd - Managing Member
Steven Boyd	8.6%	4,812,000	0	4,812,000	/s/ Steven Boyd	Steven Boyd